Top compounds associated with response to LYPD1


Feature Type Standardized
Nominal ANOVA
mRNA NPC-26 CTRPv2 pan-cancer AAC -0.026 0.5
mRNA IPR-456 CTRPv2 pan-cancer AAC -0.026 0.5
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.024 0.5
mRNA triptolide CTRPv2 pan-cancer AAC -0.024 0.5
mRNA fluvastatin CTRPv2 pan-cancer AAC 0.024 0.5
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.023 0.5
mRNA masitinib CTRPv2 pan-cancer AAC 0.024 0.6
mRNA ZSTK474 CTRPv2 pan-cancer AAC -0.025 0.6
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.024 0.6
mRNA spautin-1 CTRPv2 pan-cancer AAC -0.025 0.6
Download CSV